Vitamin Shoppe has been selected as Renaissance Capital's Featured IPO. The leading specialty retailer and direct marketer of vitamins plans to raise $136 million by offering 9,096,077 at a price range of $14.00 to $16.00. At the mid-point of the proposed range, Vitamin Shoppe will command a market value of $415.01 million. J.P. Morgan, BofA Merrill Lynch , and Barclays Capital are the lead underwriters on the deal.
Founded in 1977 as a single store in New York City, Vitamin Shoppe is now the second-largest retailer of vitamins, supplements and other health and wellness products in the US with 434 stores in 37 states. The company initially filed for an IPO almost two and a half years ago, before the IPO market virtually shut down for consumer-oriented companies in early 2008. If it finally completes its IPO this week, it will be the first traditional retailer to go public in the US since agricultural/construction equipment provider Titan Machinery (TITN) did so in December 2007.
Read our full IPO Commentary.
